These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer. Sahoo B; Arduini I; Drombosky KW; Kodali R; Sanders LH; Greenamyre JT; Wetzel R PLoS One; 2016; 11(6):e0155747. PubMed ID: 27271685 [TBL] [Abstract][Full Text] [Related]
25. Monomeric Huntingtin Exon 1 Has Similar Overall Structural Features for Wild-Type and Pathological Polyglutamine Lengths. Warner JB; Ruff KM; Tan PS; Lemke EA; Pappu RV; Lashuel HA J Am Chem Soc; 2017 Oct; 139(41):14456-14469. PubMed ID: 28937758 [TBL] [Abstract][Full Text] [Related]
26. An Intein-based Strategy for the Production of Tag-free Huntingtin Exon 1 Proteins Enables New Insights into the Polyglutamine Dependence of Httex1 Aggregation and Fibril Formation. Vieweg S; Ansaloni A; Wang ZM; Warner JB; Lashuel HA J Biol Chem; 2016 Jun; 291(23):12074-86. PubMed ID: 27002149 [TBL] [Abstract][Full Text] [Related]
29. The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract. Bravo-Arredondo JM; Kegulian NC; Schmidt T; Pandey NK; Situ AJ; Ulmer TS; Langen R J Biol Chem; 2018 Dec; 293(51):19613-19623. PubMed ID: 30315108 [TBL] [Abstract][Full Text] [Related]
30. A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles. Lee AL; Ung HM; Sands LP; Kikis EA PLoS One; 2017; 12(3):e0173644. PubMed ID: 28282438 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of polyglutamine aggregation by SIMILAR huntingtin N-terminal sequences: Prospective molecules for preclinical evaluation in Huntington's disease. Burra G; Thakur AK Biopolymers; 2017 Jul; 108(4):. PubMed ID: 28406522 [TBL] [Abstract][Full Text] [Related]
38. Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract. Hazeki N; Nakamura K; Goto J; Kanazawa I Biochem Biophys Res Commun; 1999 Mar; 256(2):361-6. PubMed ID: 10079189 [TBL] [Abstract][Full Text] [Related]
39. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors. Banerjee M; Datta M; Bhattacharyya NP Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155 [TBL] [Abstract][Full Text] [Related]
40. All-atom stability and oligomerization simulations of polyglutamine nanotubes with and without the 17-amino-acid N-terminal fragment of the Huntingtin protein. Côté S; Wei G; Mousseau N J Phys Chem B; 2012 Oct; 116(40):12168-79. PubMed ID: 22978784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]